ATP Clinical Research, Inc.

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Depression3 trials
• Alzheimer disease1 trial
• Schizophrenia1 trial

Phase

• Phase 22 trials
• Phase 32 trials

Status

• Completed3 trials
• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• COMPASS Pathways2 trials
• Boehringer Ingelheim1 trial
• Lighthouse Pharmaceuticals, Inc.1 trial
• Otsuka Pharmaceutical Development & Commercialization, Inc.1 trial

Running trials

• Recruiting

  Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

  NCT06847321· Phase 2· Lighthouse Pharmaceuticals, Inc.· Source

  Contact: Christine Som

• Active, not recruiting

  Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD

  NCT05711940· Phase 3· COMPASS Pathways· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alzheimer disease1 recruiting

Closed trials

• Completed

  A Prospective Cohort Study to Assess Clinical Effectiveness of an Investigational Digital Therapeutic (CT-155) in Patients With Experiential Negative Symptoms of Schizophrenia

  NCT06791122· Boehringer Ingelheim· Source

• Completed

  Efficacy, Safety, and Tolerability of COMP360 in Participants With TRD

  NCT05624268· Phase 3· COMPASS Pathways· Source

• Completed

  A Trial of the Safety and Efficacy of SEP-363856 in the Treatment of Adults With Major Depressive Disorder

  NCT05593029· Phase 2· Otsuka Pharmaceutical Development & Commercialization, Inc.· Source